Demplatin pegraglumer Uses, Dosage, Side Effects and more
Demplatin pegraglumer is under investigation in clinical trial NCT02043288 (Combination Therapy With NC-6004 and Gemcitabine Versus Gemcitabine Alone in Pancreatic Cancer).
| Attribute | Details |
|---|---|
| Trade Name | Demplatin pegraglumer |
| Generic | Demplatin pegraglumer |
| Demplatin pegraglumer Other Names | Demplatin pegraglumer |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
